CentriMag(R) short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days

Abstract

CentriMag proved to be a versatile, safe and effective short-term circulatory support for patients with advanced heart failure as a bridge to solution. Its use over 30 days is associated with acceptable survival and does not increase device-related complications.